smarter, simpler preclinical animal research: the power of microsampling
by Neoteryx | 1 min read
Countless scientific breakthroughs are made possible in part by preclinical research using animal subjects. Microsampling - the collection of small, precise volumes of blood, as is done using Mitra devices - represents a more humane, more efficient way of doing experimental animal research in the pharmaceutical industry.
By switching to microsampling, labs can save time, save money, and better promote the 3Rs:
- Replacement - Improve research methods
- Reduction - Reduce the overall number of animals used, by methods such as eliminating reliance on satellite populations
- Refinement - Use the latest and best in vivo technologies and move toward a more efficient and economical laboratory workflow
The advantages of switching to a microsampling workflow in preclinical workflow are:
Microsampling allows labs to cut costs, simplify processes, and eliminate expensive equipment and time-consuming labor. You can sample from the same animal at multiple time points, generating better data from fewer animals and smaller samples, while working toward the goals of reduction and refinement.
Volumetric Absorptive Microsampling (VAMS™), the technology that drives the Mitra® devices developed manufactured by Neoteryx, represents a major breakthrough in animal research. Contact one of our trained Microsampling Specialists to discuss how this technology can simplify and upgrade your preclinical work.